October 14, 2021
Cepheid News Release

Cepheid Receives CE Mark for Xpert® Xpress CoV-2/Flu/RSV plus

New "plus" version of test adds a 3rd gene target to enhance detection of future SARS-CoV-2 variants.
Cepheid has received the CE mark for Xpert® Xpress CoV-2/Flu/RSV plus, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and respiratory syncytial virus (RSV) infections from a single patient sample. The new plus version of the test provides a third gene target for SARS-CoV-2 detection to meet the challenge of future viral mutations. Xpert® Xpress CoV-2/Flu/RSV plus is designed for use on any of Cepheid’s over 35,000 GeneXpert® Systems placed worldwide, with results delivered in approximately 36 minutes.
Xpert® Xpress CoV-2/Flu/RSV plus

Multiple variants of the virus that causes COVID-19 have been documented globally during the pandemic. Viruses constantly change through mutation, and new variants of a virus are expected to occur over time. Adding a 3rd gene target to the plus version of Cepheid’s CoV-2/Flu/RSV test delivers broader coverage to mitigate the possible effects of future viral genetic drift.

Read full article on the Xpert® Xpress CoV-2/Flu/RSV plus

“This respiratory season, healthcare providers may encounter a range of viral infections with symptoms that overlap with COVID-19, including Flu A, Flu B, and respiratory syncytial virus. Having a fast and accurate test that is designed to detect current and future variants of the viruses that cause COVID-19 and influenza will become increasingly important. The ability to collect one sample and run a single, highly-sensitive multiplexed test that detects and differentiates all four viruses will provide actionable results to inform better front-line decisions within our healthcare systems.”

Dr. David Persing, MD, Ph.D.
Chief Medical and Technology Officer



Cepheid’s new East Bay Logistics Center located in Fremont will also include the distribution of their Xpert® Xpress CoV-2/Flu/RSV plus among other Xpert® Tests and GeneXpert Testing Systems.

Link to Original Article (may require registration)